Victrex PLC (VCT)

Industry Specialty Chemicals
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

576.00p

Buy

577.00p

arrow-down-6.00p (-1.03%)

Prices updated at 02 Apr 2026, 16:35 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Victrex PLC manufactures and sells high performance polymers and provides PEEK and PAEK polymer solutions. It operates in two segments namely, Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions).
FTSE All-Share
arrow-up0.59%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Basic Materials
Industry
Specialty Chemicals
Chairman
Dr. Dame Vivienne Cox
CEO
Dr. James Mathew Routh
Most recent earnings
30 Sep 2025
Fiscal year end
30 Sep 2025
Employees
1,169
Head office
Victrex Technology Centre
Thornton Cleveleys
United Kingdom
FY5 4QD
mobile
+44 1253897700
letter
cosec@victrex.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Dr. Rosalind Catherine Rivaz
Non-Executive Director, Senior Independent non-executive director
-
Dr. Dame Vivienne Cox
Non-Executive Director, Chairman
-
Mr. Brendan W D Connolly
Non-Executive Director
-
Ms. Janet Elizabeth Ashdown
Non-Executive Director
-
Mr. David Thomas
Non-Executive Director
-
Ms. Urmi Prasad Richardson
Non-Executive Director
-
Mr. Ian Clifford Melling
Executive Director, Chief Financial Officer
-
Dr. James Mathew Routh
Executive Director, Chief Executive Officer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Columbia Threadneedle Investments EMEA APAC5,470,716
CT UK Equity Income Fund5,344,194
FIL Investment Services (UK) Ltd4,453,895
M&G Investment Management Limited3,860,933
Schroder Investment Management Limited3,745,486

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
16 Feb 2026Sale
16 Feb 2026Exercise of Option
16 Feb 2026Sale of Option
12 Feb 2026Transfer in
18 Dec 2025Purchase
17 Dec 2025Sale
17 Dec 2025Transfer in
17 Dec 2025Purchase
12 Dec 2025Transfer in
12 Dec 2025D
12 Dec 2025Sale
05 Dec 2025Purchase
05 Dec 2025Purchase
08 Jul 2025Purchase
13 May 2025Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.